IL-18-secreting multiantigen targeting CAR T cells eliminate antigen-low myeloma in an immunocompetent mouse model
Blood · 2024
DOI: 10.1182/blood.2023022293 ↗Kurz gefasst
Fachartikel in der Zeitschrift Blood, 2024. Verfasst von Brandon D Ng und 15 weiteren Autor:innen. Beteiligte Einrichtung: Immunology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY. Hauptthemen laut MEDLINE: Multiple Myeloma, Interleukin-18, Immunotherapy, Adoptive, B-Cell Maturation Antigen. Die Arbeit wurde bisher 44-mal zitiert (Crossref) und nennt 96 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NCI NIH HHS, NIA NIH HHS.
Abstract (Originalsprache)
Multiple myeloma is a plasma cell malignancy that is currently incurable with conventional therapies. Following the success of CD19-targeted chimeric antigen receptor (CAR) T cells in leukemia and lymphoma, CAR T cells targeting B-cell maturation antigen (BCMA) more recently demonstrated impressive activity in relapsed and refractory myeloma patients. However, BCMA-directed therapy can fail due to weak expression of BCMA on myeloma cells, suggesting that novel approaches to better address this antigen-low disease may improve patient outcomes. We hypothesized that engineered secretion of the proinflammatory cytokine interleukin-18 (IL-18) and multiantigen targeting could improve CAR T-cell activity against BCMA-low myeloma. In a syngeneic murine model of myeloma, CAR T cells targeting the myeloma-associated antigens BCMA and B-cell activating factor receptor (BAFF-R) failed to eliminate myeloma when these antigens were weakly expressed, whereas IL-18–secreting CAR T cells targeting these antigens promoted myeloma clearance. IL-18-secreting CAR T cells developed an effector-like T-cell phenotype, promoted interferon-gamma production, reprogrammed the myeloma bone marrow microenvironment through type-I/II interferon signaling, and activated macrophages to mediate antimyeloma activity. Simultaneous targeting of weakly-expressed BCMA and BAFF-R with dual-CAR T cells enhanced T-cell:target-cell avidity, increased overall CAR signal strength, and stimulated antimyeloma activity. Dual-antigen targeting augmented CAR T-cell secretion of engineered IL-18 and facilitated elimination of larger myeloma burdens in vivo. Our results demonstrate that combination of engineered IL-18 secretion and multiantigen targeting can eliminate myeloma with weak antigen expression through distinct mechanisms.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Immunology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY.
- Department of Pharmacology, Weill Cornell Medicine, New York, NY.
- City of Hope Comprehensive Cancer Center, Duarte, CA.
- Immunology Graduate Group, University of Pennsylvania, Philadelphia, PA.
- Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD.
- Weill Cornell Medical College, New York, NY.
ORCID-Profile: Brandon D Ng, Adhithi Rajagopalan, Anastasia I Kousa, Jacob S Fischman, Sophia Chen, Alyssa Massa, Harold K Elias, Dylan Manuele, Michael Galiano, Andri L Lemarquis, Alexander P Boardman, Susan DeWolf, Jonah Pierce, Bjarne Bogen, Scott E James, Marcel R M van den Brink
Förderung
- NHLBI NIH HHS
- NCI NIH HHS
- NIA NIH HHS
Zitieren
APA
Ng, B. D., Rajagopalan, A., Kousa, A. I., Fischman, J. S., Chen, S., Massa, A., Elias, H. K., Manuele, D., Galiano, M., Lemarquis, A. L., Boardman, A. P., DeWolf, S., Pierce, J., Bogen, B., James, S. E., & van den Brink, M. R. M. (2024). IL-18-secreting multiantigen targeting CAR T cells eliminate antigen-low myeloma in an immunocompetent mouse model. Blood. https://doi.org/10.1182/blood.2023022293
Vancouver
Ng BD, Rajagopalan A, Kousa AI, Fischman JS, Chen S, Massa A, et al. IL-18-secreting multiantigen targeting CAR T cells eliminate antigen-low myeloma in an immunocompetent mouse model. Blood. 2024. doi:10.1182/blood.2023022293
BibTeX
@article{Ng2024,
author = {Ng, Brandon D and Rajagopalan, Adhithi and Kousa, Anastasia I and Fischman, Jacob S and Chen, Sophia and Massa, Alyssa and Elias, Harold K and Manuele, Dylan and Galiano, Michael and Lemarquis, Andri L and Boardman, Alexander P and DeWolf, Susan and Pierce, Jonah and Bogen, Bjarne and James, Scott E and van den Brink, Marcel R M},
title = {IL-18-secreting multiantigen targeting CAR T cells eliminate antigen-low myeloma in an immunocompetent mouse model},
journal = {Blood},
year = {2024},
doi = {10.1182/blood.2023022293}
}
EUVIMED